Pharmacological preconditioning by diazoxide and a model of 
Introduction
Several phenomena have been identified that are effective in providing a powerful cardioprotection, such as ischemic preconditioning (IPC) (Murry et al. 1986 ), ischemic postconditioning (Zhao et al. 2003) , remote ischemic conditioning (Przyklenk et al. 1993 ) and pharmacological preconditioning (Piot et al. 2008 , Galano et al. 2011 .
Myocardial adaptability to pathological conditions as well as a key role of mitochondria in the process of cardioprotection have been frequently reported. Despite some gaps and uncertainties in the findings by the studies focusing on adaptation mechanisms at the molecular level, the involvement of signaling pathways mediated by opening of mitochondrial permeability transition pores (mPTP) (Kristian et al. 2001) , protein kinase C (PKC) activation (Ytrehus and Downey 1994) , free oxygen species, or by the mitochondrial ATP-dependent K + channels (K ATP ) opening (Liu et al. 1998 ) is widely accepted. Activation of these essential mechanisms by cardioprotective phenomena leads to a decreased susceptibility of the heart to ischemia/reperfusion injury (I/R) manifesting in better preservation of contractile function and in infarct S120 Jašová et al. Vol. 65 size reduction , Ferko et al. 2015 . Preconditioning-like effect induced by experimental model of acute streptozotocin-induced diabetes mellitus (STZ-DM) is characterized by better coping of the heart with the increased pathological load (Ziegelhöffer et al. 1996) . STZ-DM hearts are characterized by the lack of oxygen consumption due to damage of electron transport chain resulting in a situation similar to ischemia or hypoxia. With regard to the adaptation of the heart to pathological conditions induced by STZ-DM, there were observed many different changes in structural and functional properties of both, cardiomyocytes and heart mitochondria (Pierce and Dhalla 1981 , Ferko et al. 2006 , Malfitano et al. 2015 . Some of these changes, like an increase in ATP synthase activity and in mitochondrial membrane fluidity, or the protection against Ca 2+ overload, were considered to be an adaptation mechanisms of heart mitochondria exposed to an acute stage of STZ-DM (Ferko et al. 2006 , Ziegelhöffer et al. 1996 . Pharmacological preconditioning is one of effective tools for induction of heart adaptation by a chemical agent that influences cardioprotective pathway. Several pharmacological substances for preventing myocardial reperfusion injury were already tested. Inhibiting the formation and opening of mPTP by cyclosporin-A (Piot et al. 2008) , free radicals scavenging by melatonin (Galano et al. 2011) or reducing the production of inflammatory mediators (Ebrahimi et al. 2014) have been found to participate in the infarct size reduction and better recovery after I/R injury.
Since the effect of mitochondrial K ATP channels openers was assumed to be cardioprotective, one of them, diazoxide, has often been used as a pharmacological tool inducing preconditioning (Garlid et al. 1997 , Sanada et al. 2001 . Consequences of the induced opening of the mitochondrial K ATP channels results in depolarization of intramitochondrial membrane by K + entry which simultaneously brings about reduction in mitochondrial calcium overload (Holmuhamedov et al. 1998) .
Diazoxide has also been recognized as an inhibitor of succinate dehydrogenase (Lenzen and Panten 1983) , therefore, the defect in the electron transport chain, succinate accumulation likewise the decrease in intracelular pH can be attributed to the effect of diazoxide. These metabolic changes contribute to the prevention of mPTP opening and simulate conditions equivalent to those of IPC (Garlid et al. 1997) .
The question remains whether there is another mechanism -similar to STZ-DM -by which diazoxide could contribute to the endogenous cardioprotection. Investigation of diazoxide effect in terms of changes in structural and functional characteristics of mitochondrial membrane can provide new information about the possible mechanism of diazoxide action in healthy and diabetic myocardium. The aim was therefore to explore the possibility of existence of another in vitro mechanism, which could be contributory to cardioprotection mediated by diazoxide treatment and assessed in terms of an increase in the mitochondrial membrane fluidity and ATP synthase activity.
Material and Methods
All experiments were performed in accordance with the European Guidelines on Laboratory Animal Care. The use and treatment of animals were also approved by the Ethics Committee of the Institute for Heart Research, SAS where the experiments were carried out.
Male Wistar rats of age 9-11 weeks (250±20 g) were kept under conditions of standard light regimen (D:L, 12:12) Metabolic state of animals was determined by estimation of glucose, cholesterol, triacylglycerols and glycohemoglobin (MultiCare, Biochemical system internation, Florence, Italy) in the blood as well as insulin in the serum (RIA kit, Linco Researech USA).
Excised heart was cut into small pieces by scissors in the presence of small volume of ice-cold isolation solution (IS, containing in mmol.l -1 : 180 KCl, 4 EDTA, 1 % bovine serum albumin, pH 7.4). Minced heart tissue was suffused with 20 ml of ice-cold IS with addition of protease 2.5 mg.g -1 of tissue and subsequently, during 2-3 min, homogenized in teflon/glass homogenizer on the ice. Tissue homogenate was processed by differential centrifugation. After 10 min centrifugation at 1000 g, the obtained supernatant together with the part of mitochondria which were in direct contact with protease were poured out and the pellet containing mitochondria was homogenized in 20 ml of ice-cold IS without protease and centrifugated again at 1000 g for 10 min. Resulting supernatant was centrifuged at 6200 g for 10 min and pellet containing mitochondria was resuspended in an albumin free IS (containing in mmol.l -1 : 180 KCl, 4 EDTA). Obtained homogenate was spunned down at 6200 g for 10 min and subsequently used for the estimation of protein concentration according to Lowry, as well as for further biophysical and biochemical investigations (Lowry et al. 1951) . The procedure of isolation of heart mitochondria was performed at 4 °C (Ziegelhöffer et al. 2009 ). Mitochondrial membrane fluorescence anisotropy was determined by using a lipophilic fluorescence probe 1,6-diphenyl-1,3,5-hexatriene (DPH). The degree of DPH fluorescence anisotropy characterizes the mobility of phospholipid acyl chains in the membrane. The measured fluorescence anisotropy of DPH thus reflects the membrane microviscosity which is a reciprocal of the membrane fluidity. Isolated mitochondria were resuspended in an isotonic buffer containing 180 KCl (mmol. and ATP (in the range of concentrations up to 40 mmol.l -1 ) according to Ziegelhöffer et al. (1996) .
Data are presented as a mean ± standard error of mean (SEM). Differences between groups were evaluated by the method of analysis of variance (ANOVA). For non-normally distributed data we used a nonparametric analysis of variance, Kruskal-Wallis test for an unpaired design or Friedman test for paired comparisons. Fitting enzyme kinetics data was made using nonlinear regression with a model of Michaelis-Menten enzyme kinetics equation. The results were compared with those obtained after standard data transformation yielding linearised dose-response curves. Method of linear regression together with testing of influential points was then used for testing the significance of relations. Statistical analyses were performed using StatsDirect 2.8.0 (3.0.161) software (Stats Direct Ltd., UK) and GraphPad Prism 6.01 (GraphPad Software, Inc., USA). Two-sided P-values are reported.
Results
Diabetic state of experimental animals was confirmed by a significant (p<0.01) increase in the levels of blood glucose, triacylglycerols, cholesterol and the content of glycohemoglobin as well as by decreased levels of blood insulin on the eighth day after the STZ injection (Table 1) . 
Control group

Diabetic group
Glucose (mmol/l) 5.20 ± 0.14 17.90 ± 0.84* Triacylglycerols (g/l)
1.22 ± 0.11 4.56 ± 0.34* Cholesterol (g/l)
1.75 ± 0.10 2.69 ± 0.14* Glycohemoglobin (% Hb) 4.12 ± 0.10 7.68 ± 0.92* Insulin (ng/ml)
1.16 ± 0.18 0.48 ± 0.06*
Results are given as mean ± SEM; n=14, * p<0.01 vs. control healthy group.
Mitochondrial membrane fluidity was measured under a combination of two factors: STZ-DM condition and treatment with diazoxide (DZX). When the effects of factors were considered separately, only the acute stage of STZ-DM yielded statistically significant increase in the membrane fluidity. The second factor, diazoxide, did not have a significant impact on this biophysical parameter. Thus, the observed significant increase in membrane fluidity upon the combination of the two factors can be attributed to the main effect of STZ-DM. Diazoxide did not independently increase membrane fluidity (Fig. 1) . Fig. 1 . Modulation of mitochondrial membrane fluidity in control healthy hearts and hearts exposed to acute streptozotocininduced diabetes mellitus and diazoxide. Experimental groups: C, isolated mitochondria from control healthy group; DM, isolated mitochondria from group with acute stage of streptozotocininduced diabetes mellitus; DZX, isolated mitochondria from control healthy hearts exposed to 7 µmol.l -1 diazoxide (in vitro); DM+DZX, isolated mitochondria from hearts with acute streptozotocin-induced diabetes mellitus exposed to 7 µmol.l -1 diazoxide (in vitro). Results are given as mean ± SEM; n=6 for each group, * p<0.05 vs. control healthy group.
Fig. 2. Activity of DNP-stimulated Mg
2+ -ATPase in mitochondria isolated from control healthy and acute streptozotocin-induced diabetic rat hearts exposed to diazoxide. Experimental groups: C, isolated mitochondria from control group; DM, isolated mitochondria from group with streptozotocin-induced diabetes mellitus; DZX, isolated mitochondria from control healthy hearts exposed to 7 µmol.l -1 diazoxide (in vitro); DM+DZX, isolated mitochondria from hearts with acute streptozotocin-induced diabetes mellitus exposed to 7 µmol.l -1 diazoxide (in vitro).
Results are given as mean ± SEM; n=7 for each group. * p<0.05 vs. control healthy group. (Fig. 2) . In order to determine the type of diazoxideenzyme interaction, the dependence of ATP synthase activity on the increasing ATP concentration (so called dose-response curves) in the presence of constant diazoxide concentration (7 µmol.l -1 ) were measured in both experimental groups (Fig. 3A,B) . Statistically significant increase (p<0.05) in V max in control as well as in diabetic group and no statistically significant change of the K m value were observed in the control as well as in the SZT-DM group (Table 2) . No significant interaction between the two factors, STZ-DM and diazoxide, was observed, which denotes that the effects of these factors on the V max can be considered separately. diazoxide in control healthy hearts and hearts exposed to acute streptozotocin-induced diabetes mellitus. (B) Lineweaver-Burk plot of mitochondrial Mg 2+ -ATPase activation. Experimental groups: C, isolated mitochondria from control healthy group; DM, isolated mitochondria from group with streptozotocin-induced diabetes mellitus; DZX, isolated mitochondria from control healthy hearts exposed to 7 µmol.l -1 diazoxide (in vitro); DM+DZX, isolated mitochondria from hearts with acute streptozotocin-induced diabetes mellitus exposed to 7 µmol.l -1 diazoxide (in vitro). Results are given as mean ± SEM; n=7 for each group. Results are given as mean ± SEM. Experimental groups: C, isolated mitochondria from control healthy hearts; DM, isolated mitochondria from hearts of animals with acute streptozotocin-induced diabetes mellitus; DZX, isolated mitochondria from control healthy hearts exposed to 7 µmol.l -1 diazoxide (in vitro); DM+DZX, isolated mitochondria from hearts of animals with acute streptozotocin-induced diabetes mellitus exposed to 7 µmol.l -1 diazoxide (in vitro). n=7 for each group, * p<0.05 vs. control healthy group.
Discussion
Our attention in this study was focused on the possibilities of pharmacological influencing of already recognized cardioprotective mechanisms induced by acute stage of STZ-DM (Tani and Neely 1988 , Ziegelhöffer et al. 1996 , Ferko et al. 2006 , Malfitano et al. 2015 . Diazoxide is considered to be an appropriate agent for modulation of the endogenous protective mechanisms. Whereas diazoxide has proven its protective effect in the physiological parameters, specifically an antiarrhythmic protection in terms of the ventricular premature beats and the total duration of ventricular tachyarrhythmia) (Matejíková et al. 2009 ), we also focused on the mechanism of diazoxide action.
Acute stage of streptozotocin-induced diabetic animal models has become a very useful platform for understanding cardioprotective mechanisms (Malfitano et al. 2015 , Liu et al. 1993 . Despite using a wide range of STZ doses (Bhadada and Goyal 2015, Mukundwa et al. 2016 ) the application of 65 mg.kg -1 STZ has been shown to be sufficient to cause DM as confirmed by altered metabolic parameters on the eighth day after STZ aplication (Table 1) . Moreover, we have already reported that induction of acute stage of STZ-DM by doses of 65 mg.kg -1 STZ results in a damage of mitochondrial electron transport chain without disconnection of oxidative phosphorylation (Ferko et al. 2006) . The decrease in oxygen utilization due to defect in electron transport chain is partially compensated by an increase in mitochondrial membrane fluidity (Ferko et al. 2008 , Waczulíková et al. 2007 ). The degree of membrane fluidity is a very important parameter influencing functional properties of proteins incorporated in the membranes, such as that of activity of mitochondrial ATP synthase (Waczulíková et al. 2002) .
In accordance with our recent data, a significant increase in the mitochondrial membrane fluidity was observed in the hearts exposed to STZ-DM ( Fig. 1 ) (Ferko et al. 2008 , Waczulíková et al. 2007 ). An elevated formation of mPTP could be one of the possible explanations of the observed mitochondrial membrane fluidization. Enhanced formation and a short-term mPTP opening observed during the acute STZ-DM resulted in mitochondrial membrane fluidization and facilitation of ATP transport without lethal damage (Ziegelhöffer-Mihalovičová et al. 1997) .
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The increase in membrane fluidity of mitochondrial membranes isolated from the hearts exposed to STZ-DM could presumably result in reducing of local friction, thus facilitating ATP synthase rotation, which was manifested by enhanced ATP synthase activity, measured as DNP-stimulated Mg 2+ -ATPase activity (Fig. 2) . The activity of mitochondrial Mg 2+ -ATPase is measured in the presence of DNP that makes mitochondrial membranes permeable to Mg 2+ ions which enter the mitochondria thus allowing determination of the total enzyme activity. Similarly, the results presented in studies by Ferko et al. (2006 Ferko et al. ( , 2008 point to the ability of myocardium to adapt on the acute pathological stimulus, STZ-DM, by using the compensative mechanisms originated in mitochondria (increase in mitochondrial membrane fluidity and Mg 2+ -ATPase activity). The effect of diazoxide did not manifest in an alteration of mitochondrial membrane lipid fluidity. Moreover, combination of STZ-DM with diazoxide did not result in an independent effect of diazoxide. The observed increase can be attributed solely to the effect of STZ-DM (Fig. 1) . Based on these results, we can assume that diazoxide did not incorporate into the lipid bilayer, neither affected its composition. The effect of diazoxide as a cardioprotective agent imitating IPC was observed in the increase of mitochondrial DNP-stimulated Mg 2+ -ATPase activity (Fig. 2) within the whole diazoxide concentration range 0 to 7 µmol.l -1 (data not shown) as was confirmed in studies by Dzeja et al. (2003) and Portenhauser et al. (1971) . Interestingly, diazoxide was able to stimulate the increase in enzyme activity independently of STZ-DM condition (Fig. 2) . Based on the results, it can be deemed reasonable to anticipate the involvement of different mechanisms for each of the phenomena leading to cardioprotection. In the model of STZ-DM we observed the supportive effect of mitochondrial membrane fluidization on the increase in mitochondrial DNP-stimulated Mg 2+ -ATPase activity. On the other hand, the increase in the enzyme activity after diazoxide treatment was not associated by changes in mitochondrial membrane fluidity, which implied existence of a different mechanism by which diazoxide stimulated the Mg 2+ -ATPase.
Focusing on the elucidation the mechanism of diazoxide action, the kinetics measurements were performed. Dependence of Mg 2+ -ATPase activity on the increasing concentration of ATP in the presence or absence of diazoxide revealed a significant elevation in V max values in all experimental groups compared to the control group (Fig. 3A,B) . No statistically significant interaction between the effects of STZ-DM and DZX was proved, and so the effect of DZX can be assumed identical irrespective of the level of the second factor (diabetic and healthy condition). Thus, we can conclude that the factors STZ-DM and DZX are related to V max completely independently. Unchanged K m values of all groups exposed to diazoxide action pointed to the fact that diazoxide did not cause any alterations in afinity of the ATP-binding site of the enzyme to the substrate ( Table 2 ). The observed changes in kinetic parameters are characteristic for a noncompetitive type of enzyme activation.
In the kinetic parameters determination, the priority was given to the measurement of actual Mg 2+ -ATPase activity, i.e. the enzyme activity of that part of mitochondria with membrane permeabilisation. Addition of DNP into the incubating medium was omited in order to avoid a possible nonspecific interaction with diazoxide. Since diazoxide is known to have a wide range of the effects depending on the used concentration (Murata et al. 200, Kowaltowski et al. 2001) , we selected one of the lowest concentrations that were proved to induce the evident protective effect in determination of DNP-stimulated Mg 2+ -ATPase activity, i.e. 7 µmol.l -1 diazoxide (Fig. 2) . We assume that acute STZ-DM seems to be a strong stimulus able to induce cardioprotective mechanisms such as modulation of mitochondrial membrane fluidity and mitochondrial ATP synthase activity in comparison with the effect of diazoxide. A combination of both experimental factors, STZ-DM+DZX, bring about a moderate increase in the parameters mentioned above with a considerable contribution of STZ-DM. Based on our experimental results we propose a new view of cardioprotection induced by diazoxide that does not act through the mitochondrial K ATP opening only, but presumably also through a direct interaction of diazoxide with the molecule of mitochondrial ATP synthase. That explanation is in accordance with the opinion by Contessi et al. (2004) who consider the stabilisation of Mg-ADP binding in catalytic site of the β subunit of mitochondrial ATP synthase as a prerequisite for the general diazoxide action.
In conclusion, the experimental findings of our study provide evidence for different mechanisms of cardioprotection induced by pharmacological preconditioning with diazoxide and those induced by acute diabetes mellitus in terms of mitochondrial membrane properties. While acute STZ-DM stimulates ATP synthase activity indirectly, presumably via changes in the local lipid environment, the effect of diazoxide seems to be enabled by a direct interaction of diazoxide with the molecule of ATP synthase. These results point to a possibility of existence of a new, previously not recognized, mechanism of diazoxide's action on the induction of myocardial protection, which is independent of its effect on K ATP channels.
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